Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Holtsträter

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 4, 2020
Bioinformatics for Cancer ImmunotherapyChristoph Holtsträter, Barbara Schrörs, Thomas Bukur, et al.
Bioinformatics (Oxford, England)|August 3, 2019
ArtiFuse-computational validation of fusion gene detection tools without relying on simulated readsPatrick Sorn, Christoph Holtsträter, Martin Löwer, et al.
Nature Biotechnology|April 5, 2022
Accurate detection of tumor-specific gene fusions reveals strongly immunogenic personal neo-antigensDavid Weber, Jonas Ibn-Salem, Patrick Sorn, et al.
Frontiers in Immunology|March 27, 2023
MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expressionBarbara Schrörs, Brett J Hos, Ikra G Yildiz, et al.
Frontiers in Oncology|August 15, 2020
Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor ModelBarbara Schrörs, Sebastian Boegel, Christian Albrecht, et al.
Bioinformatics Advances|June 12, 2024
Prediction of tumor-specific splicing from somatic mutations as a source of neoantigen candidatesFranziska Lang, Patrick Sorn, Martin Suchan, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|March 4, 2020
Bioinformatics for Cancer ImmunotherapyChristoph Holtsträter, Barbara Schrörs, Thomas Bukur, et al.
Bioinformatics (Oxford, England)|August 3, 2019
ArtiFuse-computational validation of fusion gene detection tools without relying on simulated readsPatrick Sorn, Christoph Holtsträter, Martin Löwer, et al.
Nature Biotechnology|April 5, 2022
Accurate detection of tumor-specific gene fusions reveals strongly immunogenic personal neo-antigensDavid Weber, Jonas Ibn-Salem, Patrick Sorn, et al.
Frontiers in Immunology|March 27, 2023
MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expressionBarbara Schrörs, Brett J Hos, Ikra G Yildiz, et al.
Frontiers in Oncology|August 15, 2020
Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor ModelBarbara Schrörs, Sebastian Boegel, Christian Albrecht, et al.
Bioinformatics Advances|June 12, 2024
Prediction of tumor-specific splicing from somatic mutations as a source of neoantigen candidatesFranziska Lang, Patrick Sorn, Martin Suchan, et al.
Pageof 1